Parameters | Results | |
---|---|---|
Sex (%) | Male: 627 (57.3) | Female: 468 (42.7) |
Age, median (range) | 68 (19–94) | |
Comorbidity (%) | Cancer | 206 (18.8) |
Heart failure | 131 (12.0) | |
Renal failure | 136 (12.4) | |
Chronic pulmonary obstructive disease | 32 (2.9) | |
Liver cirrhosis | 118 (10.8) | |
ASA score | 1 | 645 (58.9) |
2 | 152 (13.8) | |
3 | 298 (27.2) | |
Mental status | Alert | 1045 (95.4) |
Altered | 50 (4.5) | |
Medication (%) | Antiplatelet | 206 (18.8) |
Anticoagulant | 122 (11.1) | |
Non-steroidal anti-inflammatory drugs | 306 (27.9) | |
Hospitalization | Day, median (range) | 6.00 (1–203) |
Intensive care unit | ||
n (%) | 51 (4.65) | |
Day, median (range) | 3.00 (1–26) | |
Mortality (%) | All-cause mortality | 40 (3.7) |
Bleeding-related mortality | 23 (2.1) | |
Non-bleeding-related mortality | 17 (1.6) |